Literature DB >> 20727860

ABC efflux transporters in brain vasculature of Alzheimer's subjects.

Hasini C Wijesuriya1, Jocelyn Y Bullock, Richard L M Faull, Stephen B Hladky, Margery A Barrand.   

Abstract

Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727860     DOI: 10.1016/j.brainres.2010.08.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  52 in total

Review 1.  Targeting the neurovascular unit for treatment of neurological disorders.

Authors:  Reyna L Vangilder; Charles L Rosen; Taura L Barr; Jason D Huber
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

Review 2.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

Review 3.  Clioquinol: To harm or heal.

Authors:  Dominique R Perez; Larry A Sklar; Alexandre Chigaev
Journal:  Pharmacol Ther       Date:  2019-03-18       Impact factor: 12.310

Review 4.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

Review 5.  The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-β, and Sleep.

Authors:  Erin L Boespflug; Jeffrey J Iliff
Journal:  Biol Psychiatry       Date:  2017-12-07       Impact factor: 13.382

6.  An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter.

Authors:  Pavitra Kannan; Martin Schain; Warren W Kretzschmar; Lora Weidner; Nicholas Mitsios; Balázs Gulyás; Hans Blom; Michael M Gottesman; Robert B Innis; Matthew D Hall; Jan Mulder
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

7.  Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Kati-Sisko Vellonen; Jouni Ihalainen; Marie-Christine Boucau; Fabien Gosselet; Théo Picardat; Mikko Gynther; Katja M Kanninen; Anthony R White; Tarja Malm; Jari Koistinaho; Markus M Forsberg; Marika Ruponen
Journal:  Pharm Res       Date:  2017-09-26       Impact factor: 4.200

8.  Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET.

Authors:  Viktoria Zoufal; Thomas Wanek; Markus Krohn; Severin Mairinger; Thomas Filip; Michael Sauberer; Johann Stanek; Thomas Pekar; Martin Bauer; Jens Pahnke; Oliver Langer
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-24       Impact factor: 6.200

Review 9.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

Review 10.  Transporters as Drug Targets in Neurological Diseases.

Authors:  H Qosa; L A Mohamed; S Alqahtani; B S Abuasal; R A Hill; A Kaddoumi
Journal:  Clin Pharmacol Ther       Date:  2016-08-27       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.